Neurolitic block of the lumbar sympathetic chain improves chronic pain in a patient with critical lower limb ischemia
Bloqueio neurolítico da cadeia simpática lombar melhora dor crônica em paciente portadora de isquemia crítica de membro inferior
Elton Pereira de Sá Barreto Junior; Jedson dos Santos Nascimento; Anita Perpetua Carvalho Rocha de Castro
Abstract
Keywords
Resumo
Palavras-chave
References
Garcia LA. Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther. 2006;13:II3-9.
Davies MG. Criticial limb ischemia: epidemiology. Methodist Debakey Cardiovasc J. 2012;8:10-4.
Setacci C, Donato G, Teraa M. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42(Suppl 2):S43-59.
Hertzer NR, Beven EG, Young JR. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199:223-33.
Araujo JB, Araujo Filho JB, Ciorlin E. Células-tronco de medula óssea em isquemia crítica de membros. Rev Bras Hematol Hemoter. 2009;31(Suppl. 1):128-39.
Emmerich J. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int J Low Extrem Wounds. 2005;4:234-41.
Weitz JI, Byrne J, Clagett GP. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026-49.
Lin KB, Kin DI. Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease. Int J Stem Cells. 2009;2:11-7.
Brevetti G, Perna S, Sabba C. Effect of propionyl-l-carnitine on quality of life in intermittent claudication. Am J Cardiol. 1997;79:777-80.
Scheffler P, de la Hamette D, Gross J. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training. Circulation. 1994;90:818-22.
Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for peripheral arterial disease: a doubleblind, placebo-controlled, randomized trial of HeartBar. Vasc Med. 2000;5:11-9.
Due L. Le traitment de la tromboangeite obiliterant des membres inférieures par la resection sympathique lombaire. J Cris. 1932;37:161-231.
Yoshida WB, Lemonica L, Rollo HA. Bloqueio simpático com fenol nas oclusões arteriais crônicas de membros inferiores. Cir Vasc Angiol. 1994;10:20-4.
Holliday FA, Barendregt WB, Slappendel R. Lumbar sympathectomy in critical limb ischaemia: surgical, chemical or not at all?. Cardiovasc Surg. 1999;7:200-2.
Sanni A, Hamid A, Dunning J. Is sympathectomy of benefit in critical leg ischaemia not amenable to revascularisation?. Interact Cardiovasc Thorac Surg. 2005;4:478-83.
Nesargikar PN, Ajit MK, Eyers PS. Lumbar chemical sympathectomy in peripheral vascular disease: does it still have a role?. Int J Surg. 2009;7:145-9.
Bhattarai BK, Rahman TR, Biswas BK. Fluoroscopy guided chemical lumbar sympathectomy for lower limb ischaemic ulcers. J Nepal Med Assoc. 2006;45:295-9.
Huttner S, Huttner M, Neher M. CT-guided sympathicolysis in peripheral artery disease – indications, patient selection, and long-term results. Rofo. 2002;174:480-4.